Originalkatalog | Verfügbarkeit prüfen

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.

Awada, Ahmad, Albanell, J, Canney, P A, Dirix, Luc Y, Gil, Thierry, Cardoso, Fatima, Gascon, P, Piccart-Gebhart, Martine, Baselga, J
2008